Drug utilisation pattern in dermatology outpatient department at a tertiary care hospital
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20184197Keywords:
Drug utilization, Dermatology, Male and female OPD, Prescribing patternAbstract
Background: Skin is the part of integumentary system that constitutes the largest organ of human body and thus it is exposed to injury by various extrinsic and intrinsic factors. The skin disorders have serious detrimental effect on quality of life of the general population. The present study was planned to define the prescription pattern in terms of rationality, drug interactions and financial burden of disease to the individual. Also, in the identification of problems related to drug use such as poly-pharmacy and drug-drug interaction.
Methods: The present study was conducted in the male and female out-patient Department of Dermatology at a Tertiary Care Hospital in Hyderabad, Telangana over a period of two months. Prescriptions of 400 patients were analyzed i.e. 200 each were taken from the male and female OPD patients. An observational and cross-sectional study design was adopted for this study.
Results: Prescriptions of 400 patients were analyzed. The average number of drugs per prescription was 3.73 in male OPD and 3.59 in female OPD. The percentage of generic drugs prescribed was 84.13% in male OPD and 77.3% in female OPD, drugs prescribed by brand name was 15.82% in male OPD and 22.7% in female OPD. Antihistamines were the most commonly prescribed drugs followed by antibacterial in female OPD and antifungals in male OPD.
Conclusions: Prescription of maximum drugs was by their generic name and was dispensed free of cost to the patients from the hospital pharmacy. Almost all the drugs prescribed as oral formulation were present in the NLEM, India 2011. Whereas some topical formulations prescribed are not present in the NLEM. Therefore, were prescribed by trade name. Regular educational interventions like sensitization on pharmacovigilance may further promote rational prescribing.
References
Clark AF, Ghosh K, Tonnesen MG. Tissue Engineering for Cutaneous Wounds. J Investigative Dermatol. 2007;127:1018-29.
Engman MF. The skin: a mirror to the system. JAMA. 1919;73(21):1565-68.
Joel JJ, Jose N, Shastry CS. Patterns of Skin Disease and Prescribing Trends in Rural India. Sch Acad J Pharm. 2013;2(4):304-09.
Sjoqvist F, Birkett D. Introduction to Drug Utilization Research (WHO Booklet) New York: WHO Office of Publication; 2003. Drug utilization. In: Bramley DW, editor. 2003:76-79.
Lamichhane DC, Giri BR, Pathak OK, Panta OB, Shankar PR. Morbidity profile and prescribing patterns among outpatients in a teaching hospital in Western Nepal. MJM. 2006;9(2):126.
Cork MJ, Timmins J, Holden C, CARR J, Berry V, Tazi-Ahnini R, Ward SJ. An audit of adverse drug reactions to aqueous cream in children with atopic eczema. Pharmaceutical J. 2003;271(7277):747-8.
Dirk BR, Howard IM. Dermatologic pharmacology. In: Bertram G. Katzung (Eds.), Basic and clinical pharmacology. 10th ed. McGraw Hill Publications, Boston;2007:991-1008.
Saravanakumar RT, Prasad GS, Ragul G, Mohanta GP, Manna PK, Moorthi C. Study of prescribing pattern of topical corticosteroids in the department of dermatology in multi-speciality tertiary care teaching hospital in south India. Inj J Res Pharm Sci. 2012;3(4):685-87.
Gangadharan C, Joseph A, Sarojini PA. Pattern of skin diseases in Kerala. Indian J Dermatol Venereol Leprol. 1976;42:49-51.
ATC/DDD classification: drug utilization data constrains in developing countries. WHO Drug Inf. 2002;16:233-40. Available at: http://apps.who.int/medicinedocs/pdf/s4951e/s4951e.pdf. Accessed on June 28, 2013.
Markey P, Schattner P. Promoting evidence-based medicine in general practice-the impact of academic detailing. Fam Pract. 2001;18(4):364-66.
Pathak AK, Kumar S, Kumar M, Mohan L, Dikshit H. Study of drug utilization pattern for skin diseases in dermatology OPD of an Indian tertiary care hospital-A prescription survey. JCDR. 2016 Feb;10(2):FC01.
World Health Organization (WHO) and International Network for Rational Use of Drugs. How to Investigate Drug Use in Health Facilities: Selected Drug Use indicators. Geneva, Switzerland: WHO;1993. Available at: http://apps.who.int/medicinedocs/en/d/Js2289e/.
World Health Organization. Introduction to drug utilization research. Oslo, Norway: WHO;2003. Available at: http://apps.who.int/medicinedocs/en/d/ Js4876e.
Shankar RP, Partha P, Nagesh S. Prescribing patterns in medical outpatients. Int J Clin Pract. 2002;56(7):549-51.
Kumar AK, Chen LC, Choudhary M, Ganju S, Mahajan V, Sinha A, et al. Financing health care for all: challenges and opportunities. Lancet. 2011;377(9766):668-79.
Choudary DK, Bezbaruah BK. Prescribing pattern of analgesics in orthopedic in-patient department at tertiary care hospital in Guwahati, Assam, North East India. Indian J Parmacol. 2016;48:377-81.
Vineeta D, Sharad P, Ganachari MS, Geetanjali S, Santosh S. Assessment of drug prescribing patten and cost analysis for skin diseases in dermatological, department of tertiary care hospital: an international study. J Pharmacovig. 2016;4(3):1-6.
Gambre R, Khobragade A, Jalikar K, Patel S, Gaidhane S. Analysis of prescribing pattern of drugs among patients attending dermatology outpatient department of a tertiary care hospital. EJPMR. 2018;5(3):259-71.
Lee D, Bergman U. Studies of drug utilization. Pharmacoepidemiology. 1994;2:379-93.
